Geode Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.4M | Buy |
4,529,185
+172,638
| +4% | +$1.65M | ﹤0.01% | 1642 |
|
|
2025
Q4 | $52.9M | Buy |
4,356,547
+1,018,094
| +30% | +$12.4M | ﹤0.01% | 1442 |
|
|
2025
Q3 | $39M | Buy |
3,338,453
+54,282
| +2% | +$649K | ﹤0.01% | 1637 |
|
|
2025
Q2 | $30.5M | Sell |
3,284,171
-138,241
| -4% | -$1.08M | ﹤0.01% | 1721 |
|
|
2025
Q1 | $25.1M | Buy |
3,422,412
+186,100
| +6% | +$1.43M | ﹤0.01% | 1781 |
|
|
2024
Q4 | $27.6M | Sell |
3,236,312
-34,895
| -1% | -$340K | ﹤0.01% | 1785 |
|
|
2024
Q3 | $28.5M | Sell |
3,271,207
-180,880
| -5% | -$1.49M | ﹤0.01% | 1794 |
|
|
2024
Q2 | $23.6M | Buy |
3,452,087
+966,044
| +39% | +$5.96M | ﹤0.01% | 1843 |
|
|
2024
Q1 | $22.6M | Buy |
2,486,043
+749,229
| +43% | +$5.32M | ﹤0.01% | 1856 |
|
|
2023
Q4 | $7.75M | Buy |
1,736,814
+107,286
| +7% | +$317K | ﹤0.01% | 2472 |
|
|
2023
Q3 | $5.12M | Buy |
1,629,528
+59,624
| +4% | +$244K | ﹤0.01% | 2627 |
|
|
2023
Q2 | $8.1M | Buy |
1,569,904
+112,164
| +8% | +$667K | ﹤0.01% | 2416 |
|
|
2023
Q1 | $7.68M | Buy |
1,457,740
+47,087
| +3% | +$224K | ﹤0.01% | 2413 |
|
|
2022
Q4 | $3.96M | Buy |
1,410,653
+39,900
| +3% | +$132K | ﹤0.01% | 2777 |
|
|
2022
Q3 | $5.69M | Buy |
1,370,753
+19,328
| +1% | +$97.4K | ﹤0.01% | 2602 |
|
|
2022
Q2 | $5.43M | Sell |
1,351,425
-12,545
| -0.9% | -$47.4K | ﹤0.01% | 2660 |
|
|
2022
Q1 | $6.75M | Buy |
1,363,970
+46,631
| +4% | +$258K | ﹤0.01% | 2615 |
|
|
2021
Q4 | $9.18M | Buy |
1,317,339
+5,104
| +0.4% | +$39.6K | ﹤0.01% | 2501 |
|
|
2021
Q3 | $13.1M | Buy |
1,312,235
+7,436
| +0.6% | +$83.5K | ﹤0.01% | 2262 |
|
|
2021
Q2 | $18.5M | Buy |
1,304,799
+75,191
| +6% | +$1.14M | ﹤0.01% | 2020 |
|
|
2021
Q1 | $20.2M | Buy |
1,229,608
+139,257
| +13% | +$2.68M | ﹤0.01% | 1873 |
|
|
2020
Q4 | $22.6M | Buy |
1,090,351
+204,445
| +23% | +$3.04M | ﹤0.01% | 1646 |
|
|
2020
Q3 | $6.74M | Buy |
885,906
+72,648
| +9% | +$603K | ﹤0.01% | 2218 |
|
|
2020
Q2 | $6.77M | Buy |
813,258
+156,607
| +24% | +$1.04M | ﹤0.01% | 2163 |
|
|
2020
Q1 | $3.25M | Buy |
656,651
+85,232
| +15% | +$421K | ﹤0.01% | 2403 |
|
|
2019
Q4 | $2.26M | Buy |
571,419
+42,471
| +8% | +$148K | ﹤0.01% | 2935 |
|
|
2019
Q3 | $1.61M | Buy |
528,948
+73,663
| +16% | +$329K | ﹤0.01% | 3051 |
|
|
2019
Q2 | $2M | Buy |
455,285
+48,725
| +12% | +$180K | ﹤0.01% | 2953 |
|
|
2019
Q1 | $1.61M | Buy |
406,560
+55,887
| +16% | +$225K | ﹤0.01% | 2976 |
|
|
2018
Q4 | $1.4M | Buy |
350,673
+46,281
| +15% | +$255K | ﹤0.01% | 2959 |
|
|
2018
Q3 | $2.09M | Buy |
304,392
+15,198
| +5% | +$95.4K | ﹤0.01% | 2852 |
|
|
2018
Q2 | $1.95M | Buy |
289,194
+54,649
| +23% | +$375K | ﹤0.01% | 2873 |
|
|
2018
Q1 | $1.53M | Buy |
234,545
+58,535
| +33% | +$329K | ﹤0.01% | 2913 |
|
|
2017
Q4 | $783K | Sell |
176,010
-11,888
| -6% | -$60.7K | ﹤0.01% | 3193 |
|
|
2017
Q3 | $1.16M | Buy |
187,898
+6,013
| +3% | +$38.7K | ﹤0.01% | 3058 |
|
|
2017
Q2 | $1.69M | Buy |
181,885
+6,524
| +4% | +$63.1K | ﹤0.01% | 2830 |
|
|
2017
Q1 | $1.63M | Buy |
175,361
+36,629
| +26% | +$305K | ﹤0.01% | 2772 |
|
|
2016
Q4 | $1.16M | Buy |
138,732
+2,663
| +2% | +$20.7K | ﹤0.01% | 2919 |
|
|
2016
Q3 | $934K | Buy |
136,069
+59,857
| +79% | +$365K | ﹤0.01% | 2971 |
|
|
2016
Q2 | $377K | Buy |
76,212
+5,816
| +8% | +$57.6K | ﹤0.01% | 3336 |
|
|
2016
Q1 | $680 | Buy |
70,396
+1,042
| +2% | +$7.89K | ﹤0.01% | 3078 |
|
|
2015
Q4 | $649K | Buy |
69,354
+1,034
| +2% | +$11.2K | ﹤0.01% | 3140 |
|
|
2015
Q3 | $960K | Buy |
68,320
+4,269
| +7% | +$85.8K | ﹤0.01% | 2895 |
|
|
2015
Q2 | $1.35M | Buy |
64,051
+28,844
| +82% | +$715K | ﹤0.01% | 2744 |
|
|
2015
Q1 | $1.48M | Buy |
35,207
+6,743
| +24% | +$222K | ﹤0.01% | 2634 |
|
|
2014
Q4 | $669K | Buy |
28,464
+13,158
| +86% | +$221K | ﹤0.01% | 3048 |
|
|
2014
Q3 | $229K | Buy |
+15,306
| New | +$226K | ﹤0.01% | 3522 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
